DMT310-003 Topical in the Treatment of Acne Vulgaris
Status:
Completed
Trial end date:
2020-05-04
Target enrollment:
Participant gender:
Summary
The objective is to evaluate the tolerability, safety, and efficacy of DMT310 topical powder
mixed with diluent in male and female patients with moderate to severe facial acne vulgaris.